Multiple Micronutrient Supplements

2 Registered Brands From ৳4.00 / unit
💊 Brands & Prices (2) 📋 Indications & Uses💊 Dosage & Administration⚠️ Contraindications⚡ Side Effects & Adverse Reactions🛡️ Warnings & Precautions🔬 Pharmacology & Mechanism

💊 Brand Formulations & Prices

2 brands sorted by unit price

📖 Official Clinical Monograph

DGDA Approved Prescribing Guidelines
📋 Indications & Uses

FullCare tablet is indicated for use in improving the nutritional status of women throughout the pregnancy. This is a micronutrient supplements but not a substitute of balanced diet during pregnancy.

💊 Dosage & Administration

Take only one tablet daily starting as soon as possible after conception and continue to use 180 tablets for 6 months throughout the pregnancy or as directed by the physician. It is not recommended for children and adolescents.

⚠️ Contraindications

Individuals with known hypersensitivity to any of the ingredients.

⚡ Side Effects & Adverse Reactions

Daily intake of recommended dose has no risk of adverse health effects in almost all individuals.

🛡️ Warnings & Precautions

Accidental overdose of iron containing products is a leading cause of fatal poisoning in children under 6 years. In case of accidental overdose, call a doctor or immediately visit the nearest hospital.

🔬 Pharmacology & Mechanism

Multiple Micronutrient Supplements (MMS) is a nutritional supplement for use during pregnancy based on United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) formulation following WFIO specification. It contains 15 micronutrients including Iron and Folic Acid (IFA) at dosages that approximate the recommended dietary allowances for pregnancy. Micronutrients are only needed in very small quantities but are essential for normal physiological function, growth and development. Deficiencies of micronutrients such as vitamin A, iron, iodine and folate are particularly very common during pregnancy due to increased nutrient requirements of the mother and developing fetus. These deficiencies can negatively impact the health of the mother, her pregnancy, as well as the health of the newborn baby. Recent evidence shows that the provision of MMS for women starting early in pregnancy provides clear benefits for both women and their unborn and newborn infants, beyond IFA supplementation alone. MMS can improve birth outcomes significantly by reducing the risk of low birth weight (LBW), being born small-for-gestational age (SGA), and preterm births.